GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gossamer Bio Inc (FRA:4GB) » Definitions » Current Accrued Expense

Gossamer Bio (FRA:4GB) Current Accrued Expense : €12.16 Mil (As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Gossamer Bio Current Accrued Expense?

Gossamer Bio's Current Accrued Expense for the quarter that ended in Jun. 2024 was €12.16 Mil.

Gossamer Bio's quarterly Current Accrued Expense declined from Dec. 2023 (€19.13 Mil) to Mar. 2024 (€13.99 Mil) and declined from Mar. 2024 (€13.99 Mil) to Jun. 2024 (€12.16 Mil).

Gossamer Bio's annual Current Accrued Expense declined from Dec. 2021 (€19.29 Mil) to Dec. 2022 (€18.54 Mil) but then increased from Dec. 2022 (€18.54 Mil) to Dec. 2023 (€19.13 Mil).


Gossamer Bio Current Accrued Expense Historical Data

The historical data trend for Gossamer Bio's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gossamer Bio Current Accrued Expense Chart

Gossamer Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Accrued Expense
Get a 7-Day Free Trial 21.90 12.59 19.29 18.54 19.13

Gossamer Bio Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.83 16.10 19.13 13.99 12.16

Gossamer Bio Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


Gossamer Bio Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Gossamer Bio's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Gossamer Bio Business Description

Traded in Other Exchanges
Address
3013 Science Park Road, Suite 200, San Diego, CA, USA, 92121
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Gossamer Bio Headlines

No Headlines